MarketCap
Facebook
X
TelegramAnnual report 2025
added 05-26-2026
OpGen EV - Enterprise Value 2011-2026 | OPGN
Annual EV - Enterprise Value OpGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.67 M | 10.3 M | 14.3 M | 11.2 M | -4.02 M | 49.5 M | 5.88 M | 10.1 M | 11.2 M | 22.5 M | 9.79 M | 9.97 M | 4.99 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.5 M | -4.02 M | 12.4 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 90.27 | -2.38 % | $ 4.22 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 5.31 | -7.9 % | $ 7.06 M | USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 19.07 | -2.21 % | $ 587 M | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 21.32 | -1.3 % | $ 618 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
15.2 B | $ 128.48 | -3.44 % | $ 16.1 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Illumina
ILMN
|
23.8 B | $ 162.96 | -3.03 % | $ 25.3 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 22.34 | -3.37 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
16.5 B | $ 149.93 | -1.88 % | $ 11.8 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 102.87 | 0.05 % | $ 6.94 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 11.04 | -2.39 % | $ 1.41 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 184.42 | -0.75 % | $ 9.14 B | USA |
 |
Natera
NTRA
|
30.1 B | $ 218.67 | -1.55 % | $ 29.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 456.62 | -0.45 % | $ 13.2 B | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 151.41 | -2.46 % | $ 23.7 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.7 | 0.11 % | $ 435 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 19.4 | -1.77 % | $ 434 M | USA |
 |
Personalis
PSNL
|
380 M | $ 11.42 | -5.62 % | $ 1.02 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.22 | 0.87 % | $ 24.9 B |  Niderland |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.8 | -3.0 % | $ 284 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.15 | 0.09 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 264.51 | 1.3 % | $ 22 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 71.41 | -3.41 % | $ 4.27 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 474.35 | -1.6 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 0.71 | 3.07 % | $ 255 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 8.96 | -1.75 % | $ 1.94 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 199.73 | 1.82 % | $ 22.2 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
21.6 B | $ 367.41 | -2.4 % | $ 21.9 B | USA |